Back

Exercise-induced FXYD2 upregulation prevents VSMC phenotypic switching and vascular remodeling in Ang II-induced hypertension through PARP1/myocardin axis

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Hypertension basic pathophysiology Target Organ Damage/Left Ventricular Hypertrophy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Haiyi Yu

Peking University Third Hospital, Beijing (China)

5 More presentations in this session

Presentation thumbnail
The role of endoplasmic reticulum stress in ET-1 induced vascular smooth muscle cell signalling in hypertension
Ms K. Lam (Montreal, CA)
Abstract
Presentation thumbnail
Atherogenic dyslipidemia and pulse pressure in arterial hypertension: pathophysiological links
Professor G. Khamidullaeva (Tashkent, UZ)
Abstract
Presentation thumbnail
Topographical and Quantitative Analysis of Periarterial Nerve Fibers Surrounding the Hepatic Artery
Doctor M. Tokcan (Homburg (Saar), DE)
Abstract
Presentation thumbnail
Genetic colocalization and single-cell transcriptomic evidence link irritable bowel syndrome to blood pressure regulation
Doctor G. Li (Xi'an, CN)
Abstract
Presentation thumbnail
Effect of the rs198389 polymorphism of the NPPB gene on ambulatory blood pressure monitoring parameters in uzbek hypertensive patients
Doctor R. Alieva (Tashkent, UZ)
Abstract

Access the full session

Session thumbnail
Hypertension basic pathophysiology

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Serpina3c deficiency aggravates vascular dysfunction and VSMC dysregulation through regulating adamts4 pathway activity in obese mice
1 September 2024
thumbnail
Congress Presentation
The six-transmembrane protein Stamp2 protects from hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension via actions in mononuclear cells and CXCL12
2 September 2019
thumbnail
Congress Presentation
Prophylactic dapagliflozin attenuates pulmonary vascular remodelling, preserves right ventricular function, and maintains exercise capacity in a monocrotaline-induced pulmonary hypertension rat model
29 August 2026
thumbnail
Congress Presentation
Conditional over-expression of heme-oxygenase 1 in myelomonocytic cells reduces AngII-induced hypertension and vascular inflammation in mice
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources